Abstract
Deaths from influenza total approximately 36000 per year in the United States, while hospitalizations exceed 200000 per annum. The number of complications, hospitalizations, and deaths related to influenza among asthmatic patients is disproportionately high. Vaccination against influenza is the most important way to prevent the infection, attenuate the illness, and combat the spread of the virus. Despite Centers for Disease Control and Prevention recommendations, vaccination against influenza remains extremely low in the general population and in particular among asthmatic patients and health care providers. The emergence of a novel influenza A (H1N1) virus that maintains infectivity outside the traditional flu season and has rapidly spread worldwide may be an indication that the upcoming influenza season will be more challenging. In this article, the authors will review vaccination recommendations, common therapies against influenza, and the most important measures that can help limit the spread of the virus. They will also address motivations and barriers behind resistance to influenza vaccination.
Keywords
Get full access to this article
View all access options for this article.
